Your browser doesn't support javascript.
loading
Efficacy and Safety of Limertinib (ASK120067) in Patients With Locally Advanced or Metastatic EGFR Thr790Met-Mutated NSCLC: A Multicenter, Single-Arm, Phase 2b Study.
Shi, Yuankai; Li, Baolan; Wu, Lin; Pan, Yueyin; Pan, Zhijie; Liu, Yunpeng; Fan, Yun; Ji, Yinghua; Fang, Jian; Shi, Qin; Shi, Jianhua; Gao, Hongjun; Hu, Yanping; Wang, Xiang; He, Zhiyong; Ma, Rui; Zhang, Yu; Jiang, Da; Bai, Yuansong; Zhang, Yi; Huang, Linian; Zhou, Tong; Liu, Hailong; Wang, Daqing; Wen, Qinglian; Chen, Gongyan; Zang, Aimin; Wang, Xiuwen; Zhang, Xinri; Hu, Jianbing; Yang, Runxiang; Zhang, Guojun; Gu, Kangsheng; Wang, Lin; Wang, Qiming; Wei, Zonghui; Li, Zeng; Lu, Hongda; Zhang, Helong; Chen, Hongyu; Song, Tingting.
Afiliación
  • Shi Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, People's Republic of
  • Li B; Integrated Department, Beijing Chest Hospital, Capital Medical University, Beijing, People's Republic of China.
  • Wu L; Department of Medical Oncology-Chest (2), Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, People's Republic of China.
  • Pan Y; Cancer Chemotherapy Department, Anhui Provincial Hospital, The First Affiliated Hospital of USTC, Hefei, People's Republic of China.
  • Pan Z; Department of Respiratory Diseases, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
  • Liu Y; Department of Medical Oncology, The First Affiliated Hospital of China Medical University, Shenyang, People's Republic of China.
  • Fan Y; Department of Thoracic Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, People's Republic of China.
  • Ji Y; Medical Oncology Ward 2, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, People's Republic of China.
  • Fang J; Department of Thoracic Oncology II, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/ Beijing), Peking University Cancer Hospital and Institute, Beijing, People's Republic of China.
  • Shi Q; Oncology Department, Fuzhou Pulmonary Hospital of Fujian, Fuzhou, People's Republic of China.
  • Shi J; Department II of Medical Oncology, Linyi Cancer Hospital, Linyi, People's Republic of China.
  • Gao H; Pulmonary Oncology Department, Fifth Medical Center of Chinese PLA General Hospital, Beijing, People's Republic of China.
  • Hu Y; Department of Thoracic Oncology, Hubei Cancer Hospital, The Affiliated Cancer Hospital of Tongji School of Medicine, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  • Wang X; Department of Medical Oncology, Xuzhou Central Hospital, Xuzhou, People's Republic of China.
  • He Z; Department of Thoracic Oncology, Fujian Cancer Hospital, The Affiliated Cancer Hospital of Fujian Medical University, Fuzhou, People's Republic of China.
  • Ma R; Department II of Chest Physicians, Liaoning Cancer Hospital & Institute, Shenyang, People's Republic of China.
  • Zhang Y; Department I of Respiratory Medicine, Nanjing Chest Hospital, Medical School of Southeast University, Nanjing, People's Republic of China.
  • Jiang D; Medical of Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China.
  • Bai Y; Oncology Hematology Department, China-Japan Union Hospital of Jilin University, Changchun, People's Republic of China.
  • Zhang Y; Thoracic Surgery Department, Xuanwu Hospital, Capital Medical University, Beijing, People's Republic of China.
  • Huang L; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Bengbu Medical College, Bengbu, People's Republic of China.
  • Zhou T; Oncology Department, Changzhou Tumor Hospital, Changzhou, People's Republic of China.
  • Liu H; Department of Thoracic Medical Oncology, First People's Hospital of Chenzhou City, Chenzhou, People's Republic of China.
  • Wang D; Department of Medical Oncology, Harrison International Peace Hospital, Hengshui, People's Republic of China.
  • Wen Q; Oncology Department, The Affiliated Hospital of Southwest Medical University, Luzhou, People's Republic of China.
  • Chen G; Department of Medical Oncology, Tumor Hospital of Harbin Medical University, Harbin, People's Republic of China.
  • Zang A; Medicine Oncology, Affiliated Hospital of Hebei University, Baoding, People's Republic of China.
  • Wang X; Department of Medical Oncology, Qilu Hospital of Shandong University, Jinan, People's Republic of China.
  • Zhang X; Department of Respiratory and Critical Care Medicine, The First Hospital of Shanxi Medical University, Taiyuan, People's Republic of China.
  • Hu J; Oncology Department, Yueyang Central hospital, Yueyang, People's Republic of China.
  • Yang R; Internal Second Department, Yunnan Cancer hospital, Kunming, People's Republic of China.
  • Zhang G; Department 1 of Pulmonary & Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
  • Gu K; Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China.
  • Wang L; Department of Medical Oncology, Hainan General Hospital, Haikou, People's Republic of China.
  • Wang Q; Department of Medical Oncology, Henan Cancer Hospital, Zhengzhou, People's Republic of China.
  • Wei Z; Pulmonary and Critical Care Medicine Department, The People's Hospital of Nanchuan, Chongqing, People's Republic of China.
  • Li Z; Department of Oncology, 3201 Hospital, Hanzhong, People's Republic of China.
  • Lu H; Department of Oncology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  • Zhang H; Department of Oncology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, People's Republic of China.
  • Chen H; Jiangsu Aosaikang Pharmaceutical Co. Ltd., Nanjing, People's Republic of China.
  • Song T; Jiangsu Aosaikang Pharmaceutical Co. Ltd., Nanjing, People's Republic of China.
J Thorac Oncol ; 17(10): 1205-1215, 2022 10.
Article en En | MEDLINE | ID: mdl-35659581
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Exantema / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Thorac Oncol Año: 2022 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Exantema / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Thorac Oncol Año: 2022 Tipo del documento: Article